Trastuzumab (more commonly known under the trade name Herceptin) is a humanized monoclonal antibody that acts on the HER2/neu (erbB2) receptor. Trastuzumab's principal use is as an anti-cancer therapy in breast cancer in patients whose tumors over express (produce more than the usual amount of) this receptor. Trastuzumab is administered either once a week or once every three weeks intravenously for 30 to 90 minutes.
See more at Wikipedia.org...
Her·cep·tin A trademark for the drug trastuzumab. trastuzumab Warning - High-alert drug! Herceptin Pharmacologic class: Recombinant DNA-derived [more]Herceptin - Community and Resources
[her-SEP-tin] A type of monoclonal antibody used to detect or treat some types of cancer. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Herceptin blocks the effects of the growth factor protein HER2, which transmits growth signals to breast cancer cells. Also called trastuzumab.
Free Download Now!
